Dr. Thota is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UT Regional One Physicians, Inc
877 Jefferson Avenue
Memphis, TN 38103
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2013 - 2017
- Osmania Medical College NTR UHSClass of 2007
- Cleveland Clinic FoundationResidency, Internal Medicine
Certifications & Licensure
- TN State Medical License 2020 - 2025
- NY State Medical License 2017 - 2020
- OH State Medical License 2010 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation Start of enrollment: 2019 Dec 02
Publications & Presentations
PubMed
- 30 citationsA clinical review of small-cell carcinoma of the urinary bladder.Swapna Thota, Gaurav Kistangari, Hamed Daw, Timothy P. Spiro
Clinical Genitourinary Cancer. 2013-06-01 - 1 citationsSafety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia.Amanda Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani
Blood. 2023-03-23 - 49 citationsTofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia.B Bilori, Swapna Thota, Michael J. Clemente, Bhumika J. Patel, Andres Jerez
Leukemia. 2015-10-09
Abstracts/Posters
- Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) StudySwapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid...Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...Swapna Thota, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Clinical Outcomes for Patients with Myeloid Malignancies Harboring IDH1/2mutations after Intensive Chemotherapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Swapna Thota, MD, a Hematologist with Roswell Park Comprehensive Cancer CenterJune 11th, 2020
- Targeted Drugs and Immunotherapies May Lower Risk of Therapy-Related Hematologic CancersMay 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: